Most recent update: Sunday, April 29, 2018 - 14:56

You are here

VLU research contract

Isobar Compression awarded venous leg ulcers research contract

Isobar Compression has been awarded a research contract from the Small Business Research Initiative (SBRI) for Healthcare, to assist in a feasibly study in primary care for the treatment of venous leg ulcers. The research contract was made by SBRI for Healthcare as part of a series of awards recognising the current pressures in primary care and the need to advance the future of general practice.

Isobar Compression has been awarded a research contract from the Small Business Research Initiative (SBRI) for Healthcare, to assist in a feasibly study in primary care for the treatment of venous leg ulcers. The research contract was made by SBRI for Healthcare as part of a series of awards recognising the current pressures in primary care and the need to advance the future of general practice.

With more than 500,000 people in the UK have had venous leg ulceration, between 170-190,000 suffering from lower limb ulceration at any one time and least 80 per cent of these leg ulcers are due to problems in the veins.

Graduated compression therapy is the mainstay of treatment for venous leg ulcers and is generally applied using multi-layer bandages or compression socks. Compression socks are typically supplied in standard sizes and the pressure they produce is extremely variable and unreliable due to the wide variation in patient leg shape and size. Multi-layer bandaging is bulky and is applied by a specially-trained nurse, at least weekly, so time consuming.

Isobar Compression’s solution is to provide a compression sock that is bespoke to the individual patient. A portable 3D scanner captures at least 260,000 data points from the patient’s limb and this accurate measurement produces an exact fit for the individual leg with precise pressure to the nearest mmHg (millimetres of mercury) required. No other system in the world can do this as other manufacturers rely on tape measurements, which is subject to observer error.

The effect of Isobar compression socks on calf venous transit times has been demonstrated in research carried out at University Hospital South Manchester, UK.

In total, 22 companies will share a £2.1 million investment to develop and commercialise novel technologies. Advanced Therapeutic Materials, the parent company to Isobar Compression, received the award from the West of England Academic Health Science Network (AHSN).